Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives

Systemic treatment of advanced non-small cell lung cancer (NSCLC) has undergone remarkable changes in the last decade, with the introduction of targeted therapies and immunotherapy. The identification of activating mutations in the epidermal growth factor receptor (EGFR) gene (deletions in exon 19 [...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavacchi, Daniele, Mazzoni, Francesca, Giaccone, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735534/
https://www.ncbi.nlm.nih.gov/pubmed/31564835
http://dx.doi.org/10.2147/DDDT.S194231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735534/
https://www.ncbi.nlm.nih.gov/pubmed/31564835
http://dx.doi.org/10.2147/DDDT.S194231

Ejemplares similares